Clinical Pathology
M-A | Assessing the diagnostic performance of new commercial IGRAs for Mycobacterium tuberculosis infection
24 Jan, 2023 | 14:25h | UTC
Commentary on Twitter
Assessing the diagnostic performance of new commercial IGRAs for Mycobacterium tuberculosis infection: a systematic review and meta-analysis
✅ Just Accepted
🔓 Open Access
🔗 https://t.co/8eO3ugZdfl pic.twitter.com/Fc2AjJyIw9— Clinical Infectious Diseases (@CIDJournal) January 23, 2023
M-A | Diagnostic value of four biomarkers in detecting neonatal sepsis in low- and middle-income countries
24 Jan, 2023 | 14:21h | UTC
Retrospective Study | Serial troponin-T and long-term outcomes in suspected acute coronary syndrome
24 Jan, 2023 | 14:09h | UTC
Commentary on Twitter
Serial troponin-T and long-term outcomes in suspected acute coronary syndrome https://t.co/cTm1fJTuKl#AHA22 @ehj_ed @rladeiraslopes pic.twitter.com/0p8cO8zhzi
— European Society of Cardiology Journals (@ESC_Journals) November 7, 2022
M-A | Blood endotoxin levels as biomarker of non-alcoholic fatty liver disease
12 Jan, 2023 | 12:57h | UTC
Diagnostic accuracy study | Home waking salivary cortisone to screen for adrenal insufficiency
10 Jan, 2023 | 14:47h | UTCHome Waking Salivary Cortisone to Screen for Adrenal Insufficiency – NEJM Evidence
Commentary: At-home saliva test to diagnose adrenal insufficiency makes a difference to patients’ health – News Medical
Commentary on Twitter
This prospective study tested use of home waking salivary cortisone levels to predict adrenal insufficiency. Salivary cortisone had diagnostic accuracy similar to that of a standard adrenocorticotropin (ACTH) stimulation test. https://t.co/EYEBppBN7y#EndoTwitter #MedTwitter pic.twitter.com/RsKvnCHrUQ
— NEJM Evidence (@NEJMEvidence) January 6, 2023
RCT | Efficacy and safety of azithromycin vs. placebo to treat lower respiratory tract infections associated with low procalcitonin.
16 Dec, 2022 | 13:30h | UTCEfficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial – The Lancet Infectious Diseases (link to abstract – $ for full-text)
Commentary on Twitter
New research: Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trialhttps://t.co/EZW7YdxPPU pic.twitter.com/4zlsVN5NtT
— The Lancet Infectious Diseases (@TheLancetInfDis) December 14, 2022
SR | BNP and NT-proBNP for the diagnosis of hemodynamically significant patent ductus arteriosus in preterm neonates.
14 Dec, 2022 | 14:49h | UTC
Review | Perioperative troponin surveillance in major noncardiac surgery.
7 Dec, 2022 | 14:20h | UTC
Perspective | Should ‘daily labs’ be a quality priority in hospital medicine?
5 Dec, 2022 | 00:07h | UTCEditorial: Laboratory stewardship should be a priority in every hospital – Cleveland Clinic Journal of Medicine
Study | In hypertensive disorders of pregnancy, the levels of angiogenic factors may stratify the risk of severe preeclampsia.
10 Nov, 2022 | 14:11h | UTCCirculating Angiogenic Factor Levels in Hypertensive Disorders of Pregnancy – NEJM Evidence
Commentary on Twitter
This study measured the ratio of serum soluble fms-like tyrosine kinase (sFlt-1) to placental growth factor (PIGF) in pregnant pts hospitalized with HTN. An sFLT-1:PIGF ratio ≥ 40 stratified the risk of progressing to severe pre-eclampsia within 2 wks. https://t.co/H0uSHT2bN7 pic.twitter.com/ZKRvHsqLA4
— NEJM Evidence (@NEJMEvidence) November 9, 2022
Recommendations for laboratory testing of patients with acute myeloid leukemia.
25 Oct, 2022 | 13:21h | UTC
Position Statement | Use of biomarkers for the management of heart failure and acute coronary syndrome.
17 Oct, 2022 | 12:34h | UTC
Cohort Study | Analysis of clinical features, diagnostic tests, and biomarkers in patients with suspected Creutzfeldt-Jakob Disease.
15 Aug, 2022 | 11:47h | UTC
Commentary on Twitter
In patients with suspected Creutzfeldt-Jakob disease, CSF RT-QuIC, CSF T-tau, and stereotyped MRI anomalies were associated with diagnosis; myoclonus, stereotyped EEG anomalies, and CSF protein 14-3-3 were less helpful. #CohortStudy https://t.co/w3iaHMj3co
— JAMA Network Open (@JAMANetworkOpen) August 3, 2022
M-A | Diagnostic accuracy of urinary antigen tests for pneumococcal pneumonia among patients with acute respiratory failure suspected pneumonia.
12 Aug, 2022 | 14:28h | UTC
Real-time monitoring of blood parameters in the intensive care unit: state-of-the-art and perspectives.
12 Aug, 2022 | 14:14h | UTC
Diagnostic Test Interpretation | Serum Cystatin C for estimation of glomerular filtration rate.
9 Aug, 2022 | 12:52h | UTCSerum Cystatin C for Estimation of GFR – JAMA (free for a limited period)
Commentary on Twitter
An 80-year-old man with #type2diabetes and #hypertension was referred to the nephrology clinic for assessment of persistent hyperkalemia despite discontinuation of his ACE inhibitor. #JAMADiagnosticTestInterpretation https://t.co/kxg0yHeGUr
— JAMA (@JAMA_current) August 8, 2022
Systematic Review | Rapid, point‐of‐care antigen tests for diagnosis of SARS‐CoV‐2 infection.
29 Jul, 2022 | 12:39h | UTCRapid, point‐of‐care antigen tests for diagnosis of SARS‐CoV‐2 infection – Cochrane Library
Summary: How accurate are rapid antigen tests for diagnosing COVID-19? – Cochrane Library
Development and validation of a decision support tool for the diagnosis of acute heart failure: systematic review, meta-analysis, and modelling study.
22 Jul, 2022 | 11:18h | UTC
Commentary from the author on Twitter
In an international collaborative analysis, we developed a decision-support tool (CoDE-HF) that rules-in and rules-out acute heart failure more accurately than any approach using NT-proBNP thresholds alone- published today @bmj_latest https://t.co/JtPBEzcGqu pic.twitter.com/bCo9Xlzt5b
— Ken Lee (@KuanKenLee) June 13, 2022
Under a http://creativecommons.org/licenses/by/4.0/ license
High-sensitivity cardiac troponin and the 2021 AHA/ACC Guidelines for the evaluation and diagnosis of acute chest pain.
20 Jul, 2022 | 12:29h | UTCHigh-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Acute Chest Pain – Circulation (free for a limited period)
Commentary on Twitter
#Primer HS Cardiac Troponin & Guidelines for Evaluation and Diagnosis of Acute Check Pain #AHAJournals https://t.co/avcm6LEbgb pic.twitter.com/zs8yRe6u1y
— Circulation (@CircAHA) July 13, 2022
Using circulating tumor DNA in colorectal cancer: current and evolving practices.
18 Jul, 2022 | 10:51h | UTC
Guidelines on germline testing for urologic tumor syndromes.
15 Jul, 2022 | 12:49h | UTCGuidelines on Germline Testing for Urologic Tumor Syndromes – European Urology Focus
ESMO recommendations on the use of circulating tumor DNA assays for patients with cancer.
13 Jul, 2022 | 11:38h | UTC
Genetic testing in prostate cancer management: considerations informing primary care.
13 Jul, 2022 | 11:25h | UTC
Modern developments in germline pharmacogenomics for oncology prescribing.
13 Jul, 2022 | 11:21h | UTC
Review | The promise of precision medicine in rheumatology.
12 Jul, 2022 | 12:38h | UTCThe promise of precision medicine in rheumatology – Nature Reviews Rheumatology
Commentary on Twitter
A Review in @NatureMedicine discusses recent efforts to dissect cellular and molecular heterogeneity across multiple systemic autoimmune rheumatic diseases and future directions for implementing stratification approaches for SARD treatment. https://t.co/5EGTkQjasR pic.twitter.com/NAgbnyU96O
— Nature Portfolio (@NaturePortfolio) July 8, 2022